Johnson & Johnson is asking the U.S. Food and Drug Administration to expand the approved use of its ketamine-based antidepressant Spravato nasal spray. In a July 22 press release, the New ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has ...

At least 21 million adults in the U.S. have experienced depression. And, while oral antidepressant medications are a common treatment, they don't work for everyone. Now, the Food and Drug ...

TITUSVILLE, N.J., Jan. 21, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for ...

Parkside Psychiatric Hospital and Clinic is working to help treat people with Major Depressive Disorder. Doctors there are treating people with a drug called "Spravato." What's unique about Spravato ...

The U.S. Food and Drug Administration approved Johnson & Johnson‘s ketamine-based nasal spray as a standalone therapy for adults with treatment-resistant depression. The spray, Spravato, first ...

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, ...

At Aurora Wellness, we work with individuals seeking clarity, support, and effective treatment for a wide range of psychiatric concerns. Many of our clients are navigating challenges such as ...